Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Elucida Oncology, Inc.Startup |
Active Organization Elucida Oncology, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Discovery | US | Elucida Oncology, Inc.Startup | 17 Mar 2022 |